MedDataX Logo

TAVR for Aortic Valve Disease

NCT ID: NCT05439863

Last Updated: 2024-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-01

Study Completion Date

2037-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transcatheter aortic valve replacement (TAVR) has became an important treatment of severe aortic stenosis (AS). Several randomized clinical trials showed that TAVR was non-inferior or superior to surgical aortic valve replacement (SAVR). However, many different issues have emerged: TAVR in younger patients? valve leaflet thrombosis? transcatheter valve durability? coronary reaccess after TAVR? TAVR in bicuspid aortic valve? TAVR in aortic regurgitation? etc. Hence, a prospective, multicenter database is created to provide the real-word data for these questions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation

NCT06381271

Aortic Valve Regurgitation
RECRUITING

Long-term Prognosis and Valve Durability of TAVR

NCT06379386

Aortic Valve Stenosis and Insufficiency
RECRUITING

Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in "Real World" Chinese Patients

NCT06257043

Aortic Valve Disease Mixed
RECRUITING

The Asian Transcatheter Aortic Valve Replacement Registry

NCT02308150

Aortic Valve Stenosis Aortic Diseases
COMPLETED

Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement

NCT05261204

Prosthesis Survival Prosthesis; Cardiac, Heart, Functional Disturbance as Result
ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TAVR in aortic valve disease

transcatheter heart valve

Intervention Type DEVICE

patients with severe aortic valve disease underwent transcatheter heart valve

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transcatheter heart valve

patients with severe aortic valve disease underwent transcatheter heart valve

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Clinical diagnosis of severe aortic stenosis or aortic regurgitation
2. Patients undergo transcatheter aortic valve replacement

Exclusion Criteria

patients refuse the clinical follow-up
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nanjing First Hospital, Nanjing Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Junjie Zhang

Vice chief

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nanjing First Hospital

Nanjing, Jiangsu, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jun-Jie Zhang, MD

Role: CONTACT

[email protected]
+86-25-52271350

Jing Kan, MPH

Role: CONTACT

[email protected]
+86-25-52271398

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shao-Liang Chen

Role: primary

[email protected]
+86 13605157029

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NanjingValve Registry

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis
NCT03163329 UNKNOWN PHASE2
Multi Center Registry of Transcatheter Aortic Valve Replacement in Northeast China
NCT04988243 NOT_YET_RECRUITING NA
TAVR With Echocardiography Guidance
NCT07035847 RECRUITING NA
TRANscatheter or SurgIcal Aortic Valve ReplacemenT in All-Comers With Severe Aortic Valve Stenosis
NCT02838199 WITHDRAWN PHASE4
Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
NCT03112980 ACTIVE_NOT_RECRUITING NA
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
NCT02628899 COMPLETED NA
TAVR in Adults With Pure Severe Aortic Regurgitation
NCT05737264 UNKNOWN
The Asian Pacific TAVR Multicenter Registry
NCT02195102 UNKNOWN
TAV-in-SAV in Japanese Patients
NCT06826027 ACTIVE_NOT_RECRUITING
A Prospective, Multicenter, Observational Study of the Safety and Efficacy of Emergency Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis
NCT07108478 NOT_YET_RECRUITING
Comparison of Transcatheter Aortic Valve Replacement Using Echo Only With Echo Combined With X Ray for Patients With Aortic Stenosis
NCT07317804 NOT_YET_RECRUITING PHASE4
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
NCT01531374 COMPLETED NA
The Bicuspid Aortic Stenosis Following Transcatheter Aortic Valve Replacement Registry
NCT02394184 COMPLETED
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
NCT02701283 ACTIVE_NOT_RECRUITING NA
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
NCT01586910 ACTIVE_NOT_RECRUITING NA
Transcatheter Aortic Valve Replacement With Extracorporeal Life System Support
NCT04160624 UNKNOWN NA
Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
NCT06830499 RECRUITING
Severe Aortic Valve Stenosis and Concomitant Coronary Artery Disease in Patients Undergoing TAVI
NCT04385459 COMPLETED
Outcomes of Transcatheter Aortic Valve Implantation in Management of Severe Symptomatic Aortic Stenosis
NCT03633383 UNKNOWN
Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System
NCT03788590 UNKNOWN NA
Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation
NCT04864145 RECRUITING NA
A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Patients With Pure Aortic Regurgitation
NCT07021612 RECRUITING
Safety and Feasibility of the Transcatheter Tricuspid Valve Repair System (Trialign)
NCT04936802 UNKNOWN NA
Comparison of a Single Versus Double Perclose Technique for TAVR
NCT06173115 RECRUITING NA
The Nordic Aortic Valve Intervention Trial
NCT01057173 ACTIVE_NOT_RECRUITING NA